Evidence Related to the Use of Ancillary Drugs in Bovine Respiratory Disease (Anti-Inflammatory and Others): Are They Justified or Not?

https://doi.org/10.1016/j.cvfa.2011.12.003Get rights and content

Section snippets

Material and Methods

After consultation among the current authors, the Patient/Population, Intervention, Comparison, and Outcome of clinical importance (PICO) strategy was used. The clinical question we tried to answer was, In cattle with naturally occurring BRD, are there any beneficial effects of adding an ancillary drug to antimicrobial treatment? Parameters to be evaluated for a beneficial effect were rectal temperature, the relapse rate, failure of treatment, the short- to long-term ADG or feed efficiency, the

Search Process and Identification of Relevant Studies

Only 15 articles met the initial criteria, 14 dealt with AIDs (12 NSAIDs, 1 steroidal anti-inflammatory drug [SAID], and 1 both SAID and NSAID) and 1 with immunomodulators. The reviewing process and extraction of the data are described in Fig. 1. Briefly, 358 different articles were found using the search strategy previously mentioned. Among the 59 articles remaining after title exclusion, 36 were excluded for the following reasons: 2 were studies utilizing an experimental model, 3 were the

Discussion

The main objective of this systematic review was to evaluate ancillary treatments that may be beneficial in the treatment of BRD. Since the etiology of BRD is complex and multifactorial, it is necessary to have well-organized, published RCTs for clinicians to make decisions related to including or excluding ancillary therapies for BRD. The results reported here demonstrate that only 6 RCTs are available in the published literature for the evaluation of ancillary BRD treatment regimens in

Summary

In conclusion, scarce relevant information is actually available on the use of ancillary treatment in BRD other than NSAIDs. However, even studies on NSAIDs lack consistent reliability and validity. Well-designed RCTs of long duration are necessary to support conclusions related to the actual consequences of NSAID treatment. These studies should include short-term data (temperature, clinical improvement, relapse, or failure to treatment) as well as long-term data (productivity parameters,

First page preview

First page preview
Click to open first page preview

References (34)

  • T.E. Wittum et al.

    Relationships among treatment for respiratory tract disease, pulmonary lesions evident at slaughter, and rate of weight gain in feedlot cattle

    J Am Vet Med Assoc

    (1996)
  • M. Apley

    Antimicrobials and BRD

    Anim Health Res Rev

    (2009)
  • J. Deleforge et al.

    A field evaluation of the efficacy of tolfenamic acid and oxytetracycline in the treatment of bovine respiratory disease

    J Vet Pharmacol Ther

    (1994)
  • P.W. Lockwood et al.

    Clinical efficacy of flunixin, carprofen and ketoprofen as adjuncts to the antibacterial treatment of bovine respiratory disease

    Vet Rec

    (2003)
  • B. Elitok et al.

    Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease

    J Vet Pharmacol Ther

    (2004)
  • M.L. Van De Weerdt et al.

    Modulation of lung inflammation in the control of bovine respiratory disease

    Bovine Pract

    (1997)
  • Taylor JD, Fulton RW, Lehenbauer TW, et al. The epidemiology of bovine respiratory disease: what is the evidence for...
  • Cited by (0)

    The authors have nothing to disclose.

    View full text